236 related articles for article (PubMed ID: 26637184)
1. Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.
Nijland PG; Molenaar RJ; van der Pol SM; van der Valk P; van Noorden CJ; de Vries HE; van Horssen J
Acta Neuropathol Commun; 2015 Dec; 3():79. PubMed ID: 26637184
[TBL] [Abstract][Full Text] [Related]
2. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J
Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237
[TBL] [Abstract][Full Text] [Related]
3. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I
J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593
[TBL] [Abstract][Full Text] [Related]
4. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
[TBL] [Abstract][Full Text] [Related]
5. Chronic hypoxia in development selectively alters the activities of key enzymes of glucose oxidative metabolism in brain regions.
Lai JC; White BK; Buerstatte CR; Haddad GG; Novotny EJ; Behar KL
Neurochem Res; 2003 Jun; 28(6):933-40. PubMed ID: 12718448
[TBL] [Abstract][Full Text] [Related]
6. Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Schirmer L; Srivastava R; Kalluri SR; Böttinger S; Herwerth M; Carassiti D; Srivastava B; Gempt J; Schlegel J; Kuhlmann T; Korn T; Reynolds R; Hemmer B
Ann Neurol; 2014 Jun; 75(6):810-28. PubMed ID: 24777949
[TBL] [Abstract][Full Text] [Related]
7. Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
Nijland PG; Witte ME; van het Hof B; van der Pol S; Bauer J; Lassmann H; van der Valk P; de Vries HE; van Horssen J
Acta Neuropathol Commun; 2014 Dec; 2():170. PubMed ID: 25492529
[TBL] [Abstract][Full Text] [Related]
8. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.
Magistretti PJ; Pellerin L
Philos Trans R Soc Lond B Biol Sci; 1999 Jul; 354(1387):1155-63. PubMed ID: 10466143
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial changes within axons in multiple sclerosis.
Mahad DJ; Ziabreva I; Campbell G; Lax N; White K; Hanson PS; Lassmann H; Turnbull DM
Brain; 2009 May; 132(Pt 5):1161-74. PubMed ID: 19293237
[TBL] [Abstract][Full Text] [Related]
10. Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis.
Mizee MR; Nijland PG; van der Pol SM; Drexhage JA; van Het Hof B; Mebius R; van der Valk P; van Horssen J; Reijerkerk A; de Vries HE
Acta Neuropathol; 2014 Nov; 128(5):691-703. PubMed ID: 25149081
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of Multiple Sclerosis lesions reveals a heterogeneous expression pattern of genes involved in oligodendrogliogenesis.
Zeis T; Howell OW; Reynolds R; Schaeren-Wiemers N
Exp Neurol; 2018 Jul; 305():76-88. PubMed ID: 29596844
[TBL] [Abstract][Full Text] [Related]
12. The central role of mitochondria in axonal degeneration in multiple sclerosis.
Campbell GR; Worrall JT; Mahad DJ
Mult Scler; 2014 Dec; 20(14):1806-13. PubMed ID: 25122475
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate source influences gelatinase production by mouse astrocytes in vitro.
Massengale JL; Gasche Y; Chan PH
Glia; 2002 May; 38(3):240-5. PubMed ID: 11968061
[TBL] [Abstract][Full Text] [Related]
14. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
[TBL] [Abstract][Full Text] [Related]
15. BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions.
Kipp M; Gingele S; Pott F; Clarner T; van der Valk P; Denecke B; Gan L; Siffrin V; Zipp F; Dreher W; Baumgartner W; Pfeifenbring S; Godbout R; Amor S; Beyer C
Brain Behav Immun; 2011 Nov; 25(8):1554-68. PubMed ID: 21620951
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of distinct galectins in multiple sclerosis lesions.
Stancic M; van Horssen J; Thijssen VL; Gabius HJ; van der Valk P; Hoekstra D; Baron W
Neuropathol Appl Neurobiol; 2011 Oct; 37(6):654-71. PubMed ID: 21501208
[TBL] [Abstract][Full Text] [Related]
17. Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
van Doorn R; Nijland PG; Dekker N; Witte ME; Lopes-Pinheiro MA; van het Hof B; Kooij G; Reijerkerk A; Dijkstra C; van van der Valk P; van Horssen J; de Vries HE
Acta Neuropathol; 2012 Sep; 124(3):397-410. PubMed ID: 22810490
[TBL] [Abstract][Full Text] [Related]
18. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis.
Trapp BD; Stys PK
Lancet Neurol; 2009 Mar; 8(3):280-91. PubMed ID: 19233038
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis: a protective or a pathogenic role for heat shock protein 60 in the central nervous system?
Raine CS; Wu E; Ivanyi J; Katz D; Brosnan CF
Lab Invest; 1996 Jul; 75(1):109-23. PubMed ID: 8683935
[TBL] [Abstract][Full Text] [Related]
20. Assessing tissue damage in multiple sclerosis: a biomarker approach.
Burman J; Zetterberg H; Fransson M; Loskog AS; Raininko R; Fagius J
Acta Neurol Scand; 2014 Aug; 130(2):81-9. PubMed ID: 24571714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
